Rate and Predictors of Hesitancy toward SARS-CoV-2 Vaccine among Type 2 Diabetic Patients: Results from an Italian Survey.

COVID-19 SARS-CoV-2 vaccine type 2 diabetes vaccine hesitancy

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
04 May 2021
Historique:
received: 12 04 2021
revised: 23 04 2021
accepted: 02 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Vaccine hesitancy (VH) has been identified as one of the major health concerns of our time by the World Health Organization. It may prove especially detrimental in the light of the ongoing SARS-CoV-2 pandemic, as vaccination campaigns still represent the primary strategy against the detrimental consequences of the pandemic. Among patients suffering from type 2 diabetes mellitus (DB), who are particularly vulnerable to COVID-19, VH might represent an even more serious threat. Therefore, our study focuses on identifying potential determinants of VH among patients with type 2 diabetes. Study participants (

Identifiants

pubmed: 34064486
pii: vaccines9050460
doi: 10.3390/vaccines9050460
pmc: PMC8147990
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Science. 2020 Aug 14;369(6505):846-849
pubmed: 32576668
J Glob Health. 2021 Mar 01;11:10001
pubmed: 33767855
BMC Public Health. 2018 May 2;18(1):569
pubmed: 29716565
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802285
J Diabetes Metab Disord. 2021 Mar 31;:1-12
pubmed: 33821206
Vaccines (Basel). 2020 Nov 09;8(4):
pubmed: 33182426
Open Life Sci. 2021 Mar 25;16(1):297-302
pubmed: 33817321
Hum Vaccin Immunother. 2020 Oct 2;16(10):2565-2572
pubmed: 32209014
Medicine (Baltimore). 2021 Mar 26;100(12):e24971
pubmed: 33761654
PLoS One. 2020 Nov 11;15(11):e0242128
pubmed: 33175914
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Isr J Health Policy Res. 2021 Mar 19;10(1):26
pubmed: 33741063
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2317
pubmed: 33828623
Nat Rev Endocrinol. 2021 Jan;17(1):11-30
pubmed: 33188364
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169

Auteurs

Federica Guaraldi (F)

Pituitary Unit, IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.

Marco Montalti (M)

Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.

Zeno Di Valerio (Z)

Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.

Edoardo Mannucci (E)

Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.

Besmir Nreu (B)

Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.

Matteo Monami (M)

Diabetes Unit, Careggi Hospital and University of Florence, 50139 Florence, Italy.

Davide Gori (D)

Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, 40126 Bologna, Italy.

Classifications MeSH